ACL reconstruction

LAUSANNE, Switzerland, July 30, 2026 AB2 Bio Ltd. has reached a major commercial and regulatory milestone after Nippon Shinyaku...

LONDON, United Kingdom, July 29, 2026 Smith+Nephew has achieved a significant regulatory milestone after receiving U.S. Food and Drug...

YOKOHAMA, Japan, May 7, 2026 CoreTissue BioEngineering announced the initiation of the randomized controlled cohort in its ongoing clinical...

UNITED STATES | January 27, 2026 — ABANZA, a medical technology company focused on advancing soft-tissue fixation solutions, announced...